JNJ-79032421, a Novel Membrane-Restricted Mesothelin-Targeting T Cell–Engaging Bispecific Antibody for the Treatment of Mesothelin-Positive CancersKarine Smans, Paul R. Gavine|Molecular Cancer Therapeutics|2026Cited by 0